Navigating Reimbursement Realities: Challenges & Opportunities in Value-Based Cancer Care
February 12, 2025
On February 12, Foley partners Kinal Patel, co-chair of the firm’s Payor/Provider Convergence Area of Focus, and Adria Warren are hosting CancerX’s upcoming webinar “Navigating Reimbursement Realities: Challenges & Opportunities in Value-Based Cancer Care” with Jasper Health’s CEO Erich Mounce. The session will cover:
- Reimbursement models — What is working and what is not,
- Technology and infrastructure — The backbone of value-based care, and
- Stakeholder alignment — Keys to long-term success.
People
Related Insights
December 4, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
December 4, 2025
Foley Viewpoints
Foley Event Key Takeaways- Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shift
Foley & Lardner, Protiviti and SS&C Intralinks recently hosted an event in Foley’s Silicon Valley office at Palo Alto Center. Moderated by Foley partner Louis Lehot, the session titled "Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shifts," brought together industry leaders: JD Fay (ex-CFO, Matterport, de-SPAC’d and then sold to CoStar Group), Dan Angus (Managing Director, Nasdaq), and Andrea Vardaro Thomas (Managing Director, Protiviti). Their combined experience provided a roadmap for companies facing the volatile and rapidly shifting capital markets of 2026.
December 4, 2025
Foley Viewpoints
FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation
FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,…